Pfizer says Sutent fails in breast cancer studies WBOC TV 16 "Sunitinib (Sutent) has been thoroughly evaluated in advanced HER-2 negative breast cancer, and while we are disappointed in the results, these trials have ...
Pfizer says Sutent fails in breast cancer studies Bioscience Technology "Sunitinib (Sutent) has been thoroughly evaluated in advanced HER-2 negative breast cancer, and while we are disappointed in the results, these trials have ...
Pfizer says Sutent fails in breast cancer studies The Olympian "Sunitinib (Sutent) has been thoroughly evaluated in advanced HER-2 negative breast cancer, and while we are disappointed in the results, these trials have ...
Pfizer says Sutent fails in breast cancer studies San Luis Obispo Tribune "Sunitinib (Sutent) has been thoroughly evaluated in advanced HER-2 negative breast cancer, and while we are disappointed in the results, these trials have ...
CIRM earmarks $50M for stem cell therapies San Jose Business Journal CIRM funding will provide the lesser of $25 million or 50 percent of a project's cost to fund completion of early-stage clinical trials in less than three ...
Pfizer says Sutent fails in breast cancer studies TheNewsTribune.com "Sunitinib (Sutent) has been thoroughly evaluated in advanced HER-2 negative breast cancer, and while we are disappointed in the results, these trials have ...
Pfizer says Sutent fails in breast cancer studies Belleville News Democrat "Sunitinib (Sutent) has been thoroughly evaluated in advanced HER-2 negative breast cancer, and while we are disappointed in the results, these trials have ...
Dr. Levine Among Best Doctors of America Space Coast Medicine and Healthy Living The advisory board's primary focus is to establish clinical pathways and guidelines for patient care and to promote practice efficiencies. ...
UPI NewsTrack Health and Science News St. Louis Globe-Democrat ... to pre-clinical mouse tests can greatly reduce costly false positives, the number of animals needed for testing and the cost of pharmaceutical trials. ...
Pfizer says Sutent fails in breast cancer studies Seattle Post Intelligencer "Sunitinib (Sutent) has been thoroughly evaluated in advanced HER-2 negative breast cancer, and while we are disappointed in the results, these trials have ...
Pfizer says Sutent fails in breast cancer studies KTVZ "Sunitinib (Sutent) has been thoroughly evaluated in advanced HER-2 negative breast cancer, and while we are disappointed in the results, these trials have ...
UPDATE 2-Pfizer says Sutent breast cancer trials fail Reuters India N: Quote, Profile, Research) said on Thursday that two late-stage breast cancer trials involving its cancer drug Sutent failed to meet their goals and it ...
Pfizer ends study on potential lung cancer drug Tuscaloosa News (subscription) The company plans on continuing to study the drug candidate in clinical trials focusing on prostate, breast, and other cancers, including types of lung ...
